Navigation Links
Long Patient Waiting Times Force NHS Patients To Seek Treatment Abroad

Looks like it is time for impatient patients to travel abroad rather than wait for weeks or months to get treated// for their ailments. Recently, a woman won the right to claim compensation from the NHS for a hip replacement surgery done abroad. In yet another case, a 63-year-old British woman who traveled elsewhere gave birth to a baby, after prenatal diagnostic tests confirmed absence of any genetic disorder.

A recent case that stirred controversy was the one involving Yvonne Watts, who got her hip replacement surgery in France, tired of waiting for surgery in UK. She had claimed the amount she had paid for the surgery (£3,900) from Bedford Primary Care Trust. The court apparently ruled that she could claim the money if she could prove the delay in provision of treatment.

Such legal decisions should be made on the basis of the merits of the treatment and the condition of the patient. Owing to such case that have caught public attention, the waiting times of patients registered with the NHS are coming down.

If only the Government reaches its target of 18 weeks (from the time of referral to provision of treatment) by the end of 2008, then perhaps the need for NHS patients to travel abroad for medical treatment would be drastically reduced.

One reason behind the increasing inclination to medical tourism is also the reduced cost associated with cosmetic surgery, infertility treatment (more specifically, IVF), orthopedic surgeries such as knee and hip replacement surgeries in other countries compared to NHS costs. Countries such as India, South Africa, Malaysia, Eastern Europe and Thailand are particularly enjoying the growth of the medical tourism industry.


'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology: